Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.

Autor: Göngora-Rivera F, Soto-Hernández JL, González Esquivel D, Cook HJ, Márquez-Caraveo C, Hernández Dávila R, Santos-Zambrano J
Zdroj: Neurology; 2006 Feb 14, Vol. 66 Issue 3, p436-438, 3p
Databáze: Complementary Index